lower drug prices on behalf of Americans.
Receive emails from Patients For Affordable Drugs Now and its related organizations.
Tell your members of Congress to stand with patients and pass Medicare negotiation.
Share your story about why legislators must allow Medicare to negotiate lower drug prices.
Tell us why you want Medicare to negotiate!
Create a custom profile picture for your Facebook profile to show all of your friends that you support Medicare negotiation!
Click below to tweet at your elected representatives asking them to take action to allow Medicare to negotiate.
Our country’s drug pricing system is broken, but Congress has the power to fix it. I am calling on my elected officials to allow Medicare to negotiate lower drug prices NOW.Tweet this!
I know all too well that prescription drugs don’t work if patients can’t afford them. I am calling on my elected officials to allow Medicare to negotiate lower drug prices NOW.Tweet this!
“When I was diagnosed with type 1 diabetes, it not only meant a lifetime of managing my condition, but also the beginning of endless challenges of affording the insulin I need to keep me alive. If the government were allowed to negotiate lower drug prices, I could have hope that never again will my wife have to skip meals to make sure I can afford my life-saving medication.”— Marcus LaCourCincinnati, Ohio
“As a retired senior, I have Medicare for prescription drug coverage. The monthly price of the Imbruvica I need to manage my cancer is now over $14,000. Who can possibly afford that? We need Medicare to be able to negotiate for lower drug prices for me and all of the other patients who are struggling.”— Lynn ScarfutoHerkimer, New York
“People have to choose between eating and their medications. They have to choose between life and death. And that should not be a choice. It is long past time for Congress to pass legislation to allow Medicare to negotiate fair prescription drug prices on behalf of people like me.”— Patricia McKenzieLithonia, Georgia
“Medicare should negotiate drug prices across the board… This isn’t a partisan issue. Alzheimer’s, diabetes, and cancer don’t care if you’re a Democrat or a Republican. This is about whether or not you and your loved ones can afford the prescription drugs you need.”
“There is no reason why Americans pay two or three times as much for drugs that are manufactured in the U.S. as do people in other countries. So, we’re going to go and do something the old-fashioned way, an American tradition: negotiate to get a better price. Congress looks like it’s on its way to making [Medicare negotiation] happen, and we will do everything we can at HHS to support their efforts.”
“Our goal is to lower the cost of prescription drugs for the American people. In order to do that, it is essential we have the power to negotiate.”
“The American people are overwhelmingly of the view that when you have 50 million seniors plus in Medicare, the program ought to negotiate to get them a good deal. Who in the world doesn’t negotiate when you got all those people who are counting on you?”
“Americans pay three, four, or ten times the amount that people pay in other countries for the exact same drug. How is that fair? It’s not — in fact, it’s outrageous and it is long past time that we negotiate a better deal for Americans.”
On allowing Medicare to negotiate drug prices: “That should have been done years ago. How in the heck that never was done doesn’t make any sense at all.”
“It is an unconscionable abuse to the American people that pharma does not compete for drugs provided under Medicare Part D. We are the defenders of competition and free enterprise, so why not with pharma? Allowing Medicare to negotiate prescription drug prices for over 43 million Americans enrolled in Medicare Part D is one of the best solutions to lower medication costs and ensure access to the prescriptions they need. These negotiations will make prescription prices lower for our seniors.”
“Legislation that allows Medicare to negotiate lower drug prices on behalf of Americans will ensure we get the innovation we need at prices patients can afford. Let’s get it done.”